The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchronization Therapy

NCT02903940 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-01-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the application of Negative Atrioventricular Hysteresis (NAVH) to improve electrical synchrony in Cardiac Resynchronization Therapy (CRT) patients.

Conditions

Interventions

DEVICE

CRT+NAVH

Cardiac Resynchronization Therapy with Negative Atrioventricular Hysteresis

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2022-10-31
Completion
2022-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02903940 on ClinicalTrials.gov